3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
5
Rhabdoid Tumor
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Sarcoma, Synovial
3
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
3
Wilms Tumor
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Recurrence
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Mesothelioma
2
Medulloblastoma
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Xanthogranuloma, Juvenile
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neurofibrosarcoma
1
Nerve Sheath Neoplasms
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Inhibition, Psychological
1
Hodgkin Disease
1
Interventions
Cyclophosphamide
13
Etoposide
10
Prednisone
8
Doxorubicin
8
Whole-Body Irradiation
7
Vincristine
7
Rituximab
7
Peripheral Blood Stem Cell Transplantation
7
Melphalan
7
Brentuximab Vedotin
7
romidepsin
6
fludarabine phosphate
6
Mycophenolic Acid
6
fludarabine
5
Lenalidomide
5
Gemcitabine
5
Cytarabine
5
10-propargyl-10-deazaaminopterin
5
Tacrolimus
4
Granulocyte Colony-Stimulating Factor
4
Carmustine
4
Busulfan
4
Antilymphocyte Serum
4
pembrolizumab
3
etoposide phosphate
3
carmustine, poliferprosan 20 drug combination
3
Vorinostat
3
Sirolimus
3
Nivolumab
3
Filgrastim
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, T-Cell
×
tazemetostat
×
Clear all
No trials found.